Psychedelics and Racial Justice
Monnica T. Williams, Victor Cabral, Sonya Faber
International Journal of Mental Health and Addiction April 1, 2024 Peer reviewed DOI: 10.1007/s11469-023-01160-5 via Springer Nature
Summary
Psychedelic therapies show promise for mental health treatment but have largely excluded people of color from clinical trials, leaving fundamental clinical issues unaddressed. This narrative review examines racial trauma, ethnic minority mental health, and how psychedelic therapies can aid recovery for people of color. It also discusses potential harms and steps needed to promote culturally inclusive access, including community-based participatory research and culturally informed study designs as trials near completion and access expands.
Study at a glance
| Design | narrative review |
|---|---|
| Key finding | Psychedelic therapy research has largely excluded people of color, and culturally inclusive practices such as community-based participatory research are needed to ensure equitable access and address racial trauma. |
Abstract
Psychedelics are being studied for the treatment of numerous mental health disorders, as well as a means of bringing people together. Nonetheless, people of color and those with other marginalized identities have not been fully included. Studies and research on psychedelic-assisted therapies have largely excluded people of color, leaving out fundamental clinical issues for these populations. This paper provides a narrative review of relevant research on this topic, racial trauma, ethnic minority mental health, and how psychedelic therapies can advance recovery for people of color. It also discusses potential harms and steps needed to promote culturally inclusive access to care. Many psychedelic therapy trials are in their final stages and access is being expanded, making it important to consider equitable practices in research that can foster inclusion, such as community-based participatory research and culturally informed research design.